IceCure Medical (ICCM) Shares Outstanding (Diluted Average) (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $63.6 million in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $63.6 million, up 24.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $63.6 million (up 24.97% YoY), and the FY2025 annual result was $63.6 million, up 24.97% from the prior year.
• Shares Outstanding (Diluted Average) advanced to $63.6 million in Q4 2025 per ICCM's latest filing, from $120.0 in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $63.6 million in Q4 2025 and troughed at $120.0 in Q2 2025.
• A 5-year average of $33.3 million and a median of $36.9 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Diluted Average) surged 66.67% in 2021, then sank 100.0% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $28.5 million in 2021, then rose by 29.66% to $37.0 million in 2022, then rose by 23.29% to $45.6 million in 2023, then grew by 11.48% to $50.9 million in 2024, then increased by 24.97% to $63.6 million in 2025.
• Business Quant data shows ICCM's Shares Outstanding (Diluted Average) at $63.6 million in Q4 2025, $120.0 in Q2 2025, and $50.9 million in Q4 2024.